FDA drug center acting chief fired after commissioner's exit
Michael Erman
Reuters
Updated
Cover Media - Shareable
Supreme Court of the United States has ruled that the abortion pill mifepristone can continue to be distributed by mail while an ongoing legal battle continues.
The acting head of the U.S. Food and Drug Administration's drug center, Tracy Beth Hoeg, was fired Friday, according to her social media post, and replaced by deputy Michael Davis, the FDA's website shows.
Tracy Beth Hoeg, M.D., Ph.D., U.S. Food and Drug Administration director of the Center for Drug Evaluation and Research, participates in a Dec. 4 meeting of the Advisory Committee on Immunization Practices (ACIP) to discuss childhood vaccine schedule at the Centers for Disease Control and Prevention in Atlanta, Georgia.
Supreme Court of the United States has ruled that the abortion pill mifepristone can continue to be distributed by mail while an ongoing legal…
Tracy Beth Hoeg, M.D., Ph.D., U.S. Food and Drug Administration director of the Center for Drug Evaluation and Research, participates in a Dec. 4 meeting of the Advisory Committee on Immunization Practices (ACIP) to discuss childhood vaccine schedule at the Centers for Disease Control and Prevention in Atlanta, Georgia.
